1 citations,
April 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.
17 citations,
January 2011 in “The Korean Journal of Hepatology” Vogt-Koyanagi-Harada (VKH) disease, a rare multisystem autoimmune syndrome, was reported to occur during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. VKH disease involves ocular, neurological, and integumentary symptoms, and is thought to be triggered by an autoimmune T-cell response to a melanocyte-associated antigen. The immunological response to interferon and ribavirin may exacerbate this condition, although such a complication is very rare. This case highlights the potential for VKH disease to develop during interferon therapy in patients with chronic hepatitis C.
11 citations,
June 2022 in “Frontiers in immunology” New protein changes may be involved in the immune attack on hair follicles in alopecia areata.
1 citations,
June 2023 in “JAAD case reports” Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.
24 citations,
January 2008 in “KARGER eBooks” The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.